biotech success in switzerland and the bay area - patrik frei

www.venturevaluation.com

Comparison on European biotech locations – where does Switzerland stand?Dr. Patrik FreiJanuary 2013 | San Francisco


Country comparison

Source: Biotechgate.com by Venture Valuation

Germany France Ireland Netherlands UK Switzerland Bay Area

Biotechnology Companies 897 451 61 288 624 327 318

Biotech - Therapeutics 149 116 15 66 172 93 198

Biotech – R&D Services 607 260 22 156 399 171 99

Biotech - Other 141 75 24 66 53 63 21


Companies Founded

2004 2005 2006 2007 2008 2009 2010 2011 20120

5

10

15

20

25

30

35

Ireland UK NetherlandsFrance Germany Switzerland


Irelan

d UK

Netherl

ands

France

German

y

Switzerl

and

0%10%20%30%40%50%60%70%80%90%

100%

Private PublicSubsidiary

Irelan

d UK

Netherl

ands

France

German

y

Switzerl

and

0%10%20%30%40%50%60%70%80%90%

100%

Independent foundationSpin-off from companySpin-off from University/Public InstitutionSubsidiaryOther

Source of new companies

Patrik Frei

Left graph is very good.right one, a bit too crowded. Lets concentrate on the biggest 4 sources.


Product pipeline

Ireland

UK

Netherlands

France

Germany

Switzerland

0 50 100 150 200 250 300 350 400

51%

54%

48%

49%

48%

16%

14%

18%

22%

22%

25%

25%

27%

23%

21%

8%

7%

7%

6%

9%

Preclinical Phase I Phase II Phase III

No. of Products

Patrik Frei

I like this graph, but could you do it sideways (pipelines are always presented sideways)


2008 2009 2010 2011 20120

50

100

150

200

250

300

350

400

450

500

29 21

143

1547

286

164

455

167 160

47 34 43

144

69

125

214

146180

59

107

148

305

219

292

298 11

FranceGermanyIrelandNetherlandsSwitzerlandUnited Kingdom

Tota

l Fin

anci

ng U

SD M

Financing


7

Biotechgate• Subscription based Database with

26‘000 company profiles in over 70 countries 26‘000 products 6‘300 licensing opportunities 1’400 licensing deals

• Global Life Sciences Database to map clusters / countries• 28 country databases• Life Sciences statistics • Membership / Regional Directory


8

Global Partners

http://www.europabio.org/

http://www.naturejobs.com/


Mission

Offices HQ: Zurich with representative offices in North America, Europe and Asia (Seoul)

Employees 6 people in Switzerland, 8 representatives, JV in India

Clients Pharma, Biotech and Investors such as Novartis Venture Fund, GSK, European Investment Bank, 4SC, Arpida/Evolva, Celtic Pharma

Venture ValuationIndependent assessment and valuation of technology driven companies / products in growth industries

Life Sciences Database Biotechgate: www.biotechgate.com


Thank you for listening!Slides available on www.venturevaluation.com

Tel.: +41 (43) 321 86 60 Venture Valuation AGFax: +41 (43) 321 86 61 Kasernenstrasse 11www.venturevaluation.com 8004 Zü[email protected] Switzerland


11

Panel DiscussionTo be a successful entrepreneur in Switzerland / the Bay Area – or how to raise more money than you burn?

Participants: • Simon Meier, Investment Director, Roche Venture Fund• Simon Nebel, Managing Partner, Aravis• Christian Zahnd, CEO, Molecular Partners AG• Panel moderated by Patrik Frei, CEO Venture Valuation

biotech success in switzerland and the bay area - patrik frei

Documents